This week, we’re sharing the most recent top stories in internal medicine news.
Read more on these stories below:
More and more doctors abandoning private practice MDedge, May 27, 2021
This is the first time private practice was not the dominant approach since the American Medical Association analysis began in 2012.
Daily Cup of Coffee Linked to Lower Risk for Type 2 Diabetes Medscape, May 27, 2021
Data from large cohort studies show that daily coffee consumption is associated with a lower risk for type 2 diabetes on the order of 5%.
Colonoscopies Restricted by Pandemic: Worse CRC Outcomes to Come? Medscape, May 27, 2021
Changes in colonoscopy screening caused by the COVID-19 pandemic may have increased the risks of delayed colorectal cancer diagnosis and could lead to worse outcomes, based on recent data.
FDA Approves Dapagliflozin for Chronic Kidney Disease HCPLive, April 5, 2021
The SGLT2 inhibitor is the first of its class to receive indication for treating kidney outcomes regardless of a patient’s diabetes status.
FDA Approves Ozanimod for Adults with Ulcerative Colitis HCPLive, April 5, 2021
The treatment is also being studied for safety and efficacy in patients with Crohn’s disease.